Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001144204-19-038590
Filing Date
2019-08-08
Accepted
2019-08-08 16:36:38
Documents
62
Period of Report
2019-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q tv526035_10q.htm 10-Q 535546
2 EXHIBIT 31.1 tv526035_ex31-1.htm EX-31.1 11034
3 EXHIBIT 32.1 tv526035_ex32-1.htm EX-32.1 4536
10 GRAPHIC image_001.jpg GRAPHIC 38830
  Complete submission text file 0001144204-19-038590.txt   5500242

Data Files

Seq Description Document Type Size
4 XBRL INSTANCE DOCUMENT syn-20190630.xml EX-101.INS 1573408
5 XBRL TAXONOMY EXTENSION SCHEMA syn-20190630.xsd EX-101.SCH 44520
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE syn-20190630_cal.xml EX-101.CAL 43955
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE syn-20190630_def.xml EX-101.DEF 182679
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE syn-20190630_lab.xml EX-101.LAB 326887
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE syn-20190630_pre.xml EX-101.PRE 299740
Mailing Address 9605 MEDICAL CENTER DRIVE SUITE 270 ROCKVILLE MD 20850
Business Address 9605 MEDICAL CENTER DRIVE SUITE 270 ROCKVILLE MD 20850 (734) 332-7800
Synthetic Biologics, Inc. (Filer) CIK: 0000894158 (see all company filings)

EIN.: 133808303 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-12584 | Film No.: 191010101
SIC: 2834 Pharmaceutical Preparations